Abstract
This white paper presents a patented, integrative framework for lung cancer treatment and structured wellness support. While advances in surgery, chemotherapy, radiation, immunotherapy, and targeted therapies have improved survival outcomes, many patients continue to experience significant physical, psychological, and social burdens that affect quality of life. The patented system addresses this gap by embedding evidence-based wellness interventions directly into oncology care rather than treating them as optional adjuncts.
The model integrates conventional cancer therapies with coordinated supportive domains, including prehabilitation and structured physical activity, nutritional screening and intervention, self-management education, integrative therapies, digital health technologies, and multidisciplinary coordination. Clinical evidence supports the role of exercise in improving functional capacity and reducing fatigue and psychological distress. Nutritional interventions address malnutrition and cachexia, improving treatment tolerance and patient-reported outcomes. Structured self-management programs enhance symptom control and emotional well-being, while digital health tools improve care continuity, monitoring, and scalability. Integrative therapies and coordinated multidisciplinary collaboration further reduce symptom burden and improve patient satisfaction.
By formalizing these components within a patented, standardized system, the framework ensures consistency, scalability, and reproducibility across clinical settings. The model reflects modern oncology’s shift toward patient-centered, holistic care and leverages technology to enhance accessibility and resilience, particularly in post-pandemic healthcare environments.
Overall, the patented integrative approach represents a scalable and evidence-informed model that aligns advanced clinical treatment with comprehensive wellness support. It has the potential to improve quality of life, enhance treatment adherence and tolerance, and contribute to long-term survivorship outcomes in lung cancer care.
References
- Barrera-Garcimartin A., et al. “Effects of physical activity interventions on self-perceived health status among lung cancer patients: systematic review and meta-analysis”. Cancers 15.23 (2023): 5610.
- Ben-Arye E., et al. “Integrative oncology for patients with lung cancer: A prospective pragmatic controlled trial”. Lung Cancer 193 (2024): 107857.
- Bhurosy T, Lefevre C and Syeda Z. “Nourishing lung health: a meta-analysis and systematic review protocol of nutrition interventions for lung cancer patients”. Systematic Reviews 14.1 (2025): 1-6.
- Chewaskulyong B., et al. “Dietary Counseling Outcomes in Patients with Lung Cancer in an Upper-Middle-Income Country: An Open-Label Randomized Controlled Trial”. Journal of Clinical Medicine 13.17 (2024): 5236.
- Conte E., et al. “Enhancing Quality of Life in People with Lung Cancer: An Integrative Program of Yoga, Education, and Group Support”. Integrative Cancer Therapies 24 (2025): 15347354251385246.
- Dai B., et al. “CACA guidelines for holistic integrative management of prostate cancer”. Holistic Integrative Oncology 3.1 (2024): 47.
- De D and Dasgupta S. “Integrating combination therapies in lung cancer treatment: A comprehensive review of current approaches and future directions”. Discover Applied Sciences 7.11 (2025): 1-18.
- Elkefi S., et al. “Systematic review on the technology’s role in supporting lung cancer patients in the treatment journey”. NPJ Digital Medicine 8.1 (2025): 516.
- Fok RWY and Deng G. “Integrative, Complementary, and Alternative Therapies in Lung Cancer Care”. In: Lung Cancer Navigation and Care: A Comprehensive Guide for Navigators and Allied Health Professionals. Springer Nature Switzerland (2025): 283-300.
- Granger CL., et al. “Home-based exercise and self-management after lung cancer resection: a randomized clinical trial”. JAMA Network Open 7.12 (2024): e2447325.
- Langley JE., et al. “Prehabilitation Program for Lung and Esophageal Cancers (Boosting Recovery and Activity Through Early Wellness): Protocol for a Nonrandomized Trial”. JMIR Research Protocols 14.1 (2025): e60791.
- Lei J., et al. “An exercise prescription for patients with lung cancer improves the quality of life, depression, and anxiety”. Frontiers in Public Health 10 (2022): 1050471.
- Li G., et al. “Digital Therapeutics-Based Cardio-Oncology Rehabilitation for Lung Cancer Survivors: Randomized Controlled Trial”. JMIR mHealth and uHealth 13 (2025): e60115.
- Li Z, Wu J and Liu Z. “Effects of nutritional education intervention on frailty status in lung cancer patients: A randomized controlled trial”. The Journal of Nutrition, Health and Aging 29.10 (2025): 100645.
- Liu F., et al. “Early Nutritional Intervention in Patients with Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy: A Phase II Prospective Study”. Nutrients 17.8 (2025): 1389.
- Round T., et al. “COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary”. British Journal of Cancer 125.5 (2021): 629-640.
- Rowntree RA and Hosseinzadeh H. “Lung cancer and self-management interventions: a systematic review of randomised controlled trials”. International Journal of Environmental Research and Public Health 19.1 (2022): 536.
- Wade-Mcbane K., et al. “Prehabilitation in the lung cancer pathway: a scoping review”. BMC Cancer 23.1 (2023): 747.
- Weber M., et al. “Efficacy of a digital lifestyle intervention on health-related QUAlity of life in non-small cell LUng CAncer survivors following inpatient rehabilitation: protocol of the QUALUCA Swiss multicentre randomised controlled trial”. BMJ Open 14.3 (2024): e081397.
- Werblińska A., et al. “The Impact of Nutritional Support on Outcomes of Lung Cancer Surgery-Narrative Review”. Journal of Clinical Medicine 14.9 (2025): 3197.
- Xi Z., et al. “Traditional Chinese medicine in lung cancer treatment”. Molecular Cancer 24.1 (2025): 57.